4 ms·

India ignores other countries patents on medical things. Not sure what the legal justification is, but the actual justification is obvious.

segfaultbuserr 6y ago
Yes, we all know it, but this is the only thing I know about biotech and Pharma in India. It doesn't really tell how "much more stronger" the industry is than IT, which is why I asked for a citation.
dragonsh 6y ago
Not sure what are you implying, this isn't true India plays by WTO and international rules [1]. It uses provisions enshrined in the bilateral treaty and also the rules of global trade. India still today do not support evergreening of patent's by incremental changes. It only grant patents to original innovations. If you need more information about it probably read the 1970 patent act [2], in India which started those specific innovations in pharmaceutical formulations and made medicines affordable not just for India, but for most of Africa and many developing countries. [1] https://www.wto.org/english/tratop_e/dispu_e/cases_e/ds50_e.htm https://www.wto.org/english/tratop_e/dispu_e/cases_e/ds50_e.... [2] http://ipindia.nic.in/writereaddata/Portal/IPOAct/1_31_1_patent-act-1970-11march2015.pdf http://ipindia.nic.in/writereaddata/Portal/IPOAct/1_31_1_pat...
- pstrateman 6y ago
  Sounds like the legal justification.
markdown 6y ago
> India ignores other countries patents on medical things. And thank goodness for that. Millions upon millions of lives in the developed world have been saved by Indian generics. > Not sure what the legal justification is It's a sovereign nation.
matheusmoreira 6y ago
India is not alone. Brazil and several other countries have resorted to the same measures. https://en.wikipedia.org/wiki/Compulsory_license https://en.wikipedia.org/wiki/Compulsory_license
naruvimama 6y ago
"Evergreening" isn't a legitimate practice but exist just as tax havens and gambling do. The US is a very poor example of getting things right in healthcare, the prices of healthcare are inflated to astronomical rates so insurance can make a cool profit. The price of medicines in the US is a poor scale to use across the world.

segfaultbuserr 6y ago

Yes, we all know it, but this is the only thing I know about biotech and Pharma in India. It doesn't really tell how "much more stronger" the industry is than IT, which is why I asked for a citation.

dragonsh 6y ago

Not sure what are you implying, this isn't true India plays by WTO and international rules [1]. It uses provisions enshrined in the bilateral treaty and also the rules of global trade. India still today do not support evergreening of patent's by incremental changes. It only grant patents to original innovations. If you need more information about it probably read the 1970 patent act [2], in India which started those specific innovations in pharmaceutical formulations and made medicines affordable not just for India, but for most of Africa and many developing countries. [1] https://www.wto.org/english/tratop_e/dispu_e/cases_e/ds50_e.htm https://www.wto.org/english/tratop_e/dispu_e/cases_e/ds50_e.... [2] http://ipindia.nic.in/writereaddata/Portal/IPOAct/1_31_1_patent-act-1970-11march2015.pdf http://ipindia.nic.in/writereaddata/Portal/IPOAct/1_31_1_pat...

pstrateman 6y ago
Sounds like the legal justification.

markdown 6y ago

> India ignores other countries patents on medical things. And thank goodness for that. Millions upon millions of lives in the developed world have been saved by Indian generics. > Not sure what the legal justification is It's a sovereign nation.

matheusmoreira 6y ago

India is not alone. Brazil and several other countries have resorted to the same measures. https://en.wikipedia.org/wiki/Compulsory_license https://en.wikipedia.org/wiki/Compulsory_license

naruvimama 6y ago

"Evergreening" isn't a legitimate practice but exist just as tax havens and gambling do. The US is a very poor example of getting things right in healthcare, the prices of healthcare are inflated to astronomical rates so insurance can make a cool profit. The price of medicines in the US is a poor scale to use across the world.